nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Sufentanil—CYP3A4—bone cancer	0.018	0.372	CrCbGaD
Remifentanil—Alfentanil—CYP3A4—bone cancer	0.0168	0.346	CrCbGaD
Remifentanil—Lymphopenia—Doxorubicin—bone cancer	0.00959	0.0101	CcSEcCtD
Remifentanil—Body temperature decreased—Epirubicin—bone cancer	0.00946	0.00994	CcSEcCtD
Remifentanil—Hypothermia—Epirubicin—bone cancer	0.00946	0.00994	CcSEcCtD
Remifentanil—Hypoxia—Methotrexate—bone cancer	0.00892	0.00937	CcSEcCtD
Remifentanil—Hypothermia—Doxorubicin—bone cancer	0.00875	0.0092	CcSEcCtD
Remifentanil—Body temperature decreased—Doxorubicin—bone cancer	0.00875	0.0092	CcSEcCtD
Remifentanil—Nasal congestion—Cisplatin—bone cancer	0.00823	0.00865	CcSEcCtD
Remifentanil—Amnesia—Cisplatin—bone cancer	0.00798	0.00838	CcSEcCtD
Remifentanil—Pethidine—CYP3A4—bone cancer	0.00755	0.156	CrCbGaD
Remifentanil—Ileus—Epirubicin—bone cancer	0.00749	0.00787	CcSEcCtD
Remifentanil—Nystagmus—Epirubicin—bone cancer	0.00742	0.0078	CcSEcCtD
Remifentanil—Pleural effusion—Methotrexate—bone cancer	0.0074	0.00778	CcSEcCtD
Remifentanil—Haemoptysis—Epirubicin—bone cancer	0.00716	0.00753	CcSEcCtD
Remifentanil—Ventricular arrhythmia—Epirubicin—bone cancer	0.00716	0.00753	CcSEcCtD
Remifentanil—Ileus—Doxorubicin—bone cancer	0.00693	0.00728	CcSEcCtD
Remifentanil—Pleural effusion—Epirubicin—bone cancer	0.00692	0.00728	CcSEcCtD
Remifentanil—Nystagmus—Doxorubicin—bone cancer	0.00687	0.00722	CcSEcCtD
Remifentanil—Hypokalaemia—Cisplatin—bone cancer	0.00682	0.00717	CcSEcCtD
Remifentanil—Nasopharyngitis—Cisplatin—bone cancer	0.0067	0.00704	CcSEcCtD
Remifentanil—Apnoea—Methotrexate—bone cancer	0.00668	0.00702	CcSEcCtD
Remifentanil—Ventricular arrhythmia—Doxorubicin—bone cancer	0.00663	0.00697	CcSEcCtD
Remifentanil—Haemoptysis—Doxorubicin—bone cancer	0.00663	0.00697	CcSEcCtD
Remifentanil—Pleural effusion—Doxorubicin—bone cancer	0.00641	0.00673	CcSEcCtD
Remifentanil—Musculoskeletal stiffness—Methotrexate—bone cancer	0.00632	0.00664	CcSEcCtD
Remifentanil—Abdominal discomfort—Cisplatin—bone cancer	0.00621	0.00653	CcSEcCtD
Remifentanil—Oliguria—Methotrexate—bone cancer	0.00615	0.00646	CcSEcCtD
Remifentanil—Fentanyl—CYP3A4—bone cancer	0.00614	0.127	CrCbGaD
Remifentanil—Ventricular extrasystoles—Epirubicin—bone cancer	0.00587	0.00617	CcSEcCtD
Remifentanil—Oliguria—Epirubicin—bone cancer	0.00575	0.00605	CcSEcCtD
Remifentanil—Renal failure—Cisplatin—bone cancer	0.00568	0.00597	CcSEcCtD
Remifentanil—Dyskinesia—Epirubicin—bone cancer	0.00564	0.00593	CcSEcCtD
Remifentanil—Atrioventricular block—Epirubicin—bone cancer	0.00547	0.00574	CcSEcCtD
Remifentanil—Ventricular extrasystoles—Doxorubicin—bone cancer	0.00543	0.00571	CcSEcCtD
Remifentanil—Oliguria—Doxorubicin—bone cancer	0.00532	0.0056	CcSEcCtD
Remifentanil—Hiccups—Epirubicin—bone cancer	0.0053	0.00557	CcSEcCtD
Remifentanil—Bradycardia—Cisplatin—bone cancer	0.00528	0.00555	CcSEcCtD
Remifentanil—Dyskinesia—Doxorubicin—bone cancer	0.00522	0.00549	CcSEcCtD
Remifentanil—Hyperkalaemia—Epirubicin—bone cancer	0.00521	0.00547	CcSEcCtD
Remifentanil—Atrioventricular block—Doxorubicin—bone cancer	0.00506	0.00532	CcSEcCtD
Remifentanil—Pulmonary oedema—Methotrexate—bone cancer	0.00504	0.0053	CcSEcCtD
Remifentanil—Visual impairment—Cisplatin—bone cancer	0.005	0.00525	CcSEcCtD
Remifentanil—Hiccups—Doxorubicin—bone cancer	0.00491	0.00516	CcSEcCtD
Remifentanil—Hyperkalaemia—Doxorubicin—bone cancer	0.00482	0.00507	CcSEcCtD
Remifentanil—Flushing—Cisplatin—bone cancer	0.00481	0.00506	CcSEcCtD
Remifentanil—Cardiac disorder—Cisplatin—bone cancer	0.00481	0.00506	CcSEcCtD
Remifentanil—Pulmonary oedema—Epirubicin—bone cancer	0.00472	0.00496	CcSEcCtD
Remifentanil—Immune system disorder—Cisplatin—bone cancer	0.00468	0.00492	CcSEcCtD
Remifentanil—Mediastinal disorder—Cisplatin—bone cancer	0.00467	0.00491	CcSEcCtD
Remifentanil—Arrhythmia—Cisplatin—bone cancer	0.00463	0.00487	CcSEcCtD
Remifentanil—Erythema—Cisplatin—bone cancer	0.00451	0.00474	CcSEcCtD
Remifentanil—Hepatic function abnormal—Epirubicin—bone cancer	0.0044	0.00463	CcSEcCtD
Remifentanil—Pulmonary oedema—Doxorubicin—bone cancer	0.00437	0.00459	CcSEcCtD
Remifentanil—Visual disturbance—Methotrexate—bone cancer	0.00434	0.00456	CcSEcCtD
Remifentanil—Tremor—Cisplatin—bone cancer	0.00423	0.00444	CcSEcCtD
Remifentanil—Anaemia—Cisplatin—bone cancer	0.00417	0.00438	CcSEcCtD
Remifentanil—Hepatic function abnormal—Doxorubicin—bone cancer	0.00408	0.00428	CcSEcCtD
Remifentanil—Renal impairment—Epirubicin—bone cancer	0.00404	0.00425	CcSEcCtD
Remifentanil—Convulsion—Cisplatin—bone cancer	0.00391	0.00411	CcSEcCtD
Remifentanil—Anxiety—Cisplatin—bone cancer	0.00383	0.00402	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00382	0.00401	CcSEcCtD
Remifentanil—Renal impairment—Doxorubicin—bone cancer	0.00374	0.00393	CcSEcCtD
Remifentanil—Oedema—Cisplatin—bone cancer	0.00368	0.00387	CcSEcCtD
Remifentanil—Anaphylactic shock—Cisplatin—bone cancer	0.00368	0.00387	CcSEcCtD
Remifentanil—Cardiac arrest—Epirubicin—bone cancer	0.00366	0.00385	CcSEcCtD
Remifentanil—Nervous system disorder—Cisplatin—bone cancer	0.00361	0.0038	CcSEcCtD
Remifentanil—Thrombocytopenia—Cisplatin—bone cancer	0.00361	0.00379	CcSEcCtD
Remifentanil—Tachycardia—Cisplatin—bone cancer	0.0036	0.00378	CcSEcCtD
Remifentanil—Skin disorder—Cisplatin—bone cancer	0.00358	0.00376	CcSEcCtD
Remifentanil—Hyperhidrosis—Cisplatin—bone cancer	0.00356	0.00374	CcSEcCtD
Remifentanil—Hypokalaemia—Epirubicin—bone cancer	0.0035	0.00368	CcSEcCtD
Remifentanil—Hypotension—Cisplatin—bone cancer	0.00344	0.00362	CcSEcCtD
Remifentanil—Nasopharyngitis—Epirubicin—bone cancer	0.00344	0.00362	CcSEcCtD
Remifentanil—Abdominal discomfort—Methotrexate—bone cancer	0.00341	0.00358	CcSEcCtD
Remifentanil—Cardiac arrest—Doxorubicin—bone cancer	0.00339	0.00356	CcSEcCtD
Remifentanil—Dysphagia—Epirubicin—bone cancer	0.00333	0.0035	CcSEcCtD
Remifentanil—Dysuria—Methotrexate—bone cancer	0.00332	0.00349	CcSEcCtD
Remifentanil—Paraesthesia—Cisplatin—bone cancer	0.00331	0.00348	CcSEcCtD
Remifentanil—Dyspnoea—Cisplatin—bone cancer	0.00328	0.00345	CcSEcCtD
Remifentanil—Hypokalaemia—Doxorubicin—bone cancer	0.00324	0.00341	CcSEcCtD
Remifentanil—Bronchitis—Epirubicin—bone cancer	0.0032	0.00336	CcSEcCtD
Remifentanil—Pneumonia—Methotrexate—bone cancer	0.00319	0.00335	CcSEcCtD
Remifentanil—Nasopharyngitis—Doxorubicin—bone cancer	0.00318	0.00335	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Cisplatin—bone cancer	0.00318	0.00334	CcSEcCtD
Remifentanil—Pain—Cisplatin—bone cancer	0.00315	0.00331	CcSEcCtD
Remifentanil—Renal failure—Methotrexate—bone cancer	0.00312	0.00327	CcSEcCtD
Remifentanil—Dysuria—Epirubicin—bone cancer	0.00311	0.00327	CcSEcCtD
Remifentanil—Dysphagia—Doxorubicin—bone cancer	0.00308	0.00323	CcSEcCtD
Remifentanil—Sweating—Methotrexate—bone cancer	0.00304	0.00319	CcSEcCtD
Remifentanil—Feeling abnormal—Cisplatin—bone cancer	0.00304	0.00319	CcSEcCtD
Remifentanil—Haematuria—Methotrexate—bone cancer	0.00302	0.00318	CcSEcCtD
Remifentanil—Hyperglycaemia—Epirubicin—bone cancer	0.003	0.00315	CcSEcCtD
Remifentanil—Pneumonia—Epirubicin—bone cancer	0.00298	0.00314	CcSEcCtD
Remifentanil—Bronchitis—Doxorubicin—bone cancer	0.00296	0.00311	CcSEcCtD
Remifentanil—Renal failure—Epirubicin—bone cancer	0.00292	0.00306	CcSEcCtD
Remifentanil—Body temperature increased—Cisplatin—bone cancer	0.00291	0.00306	CcSEcCtD
Remifentanil—Dysuria—Doxorubicin—bone cancer	0.00288	0.00302	CcSEcCtD
Remifentanil—Haemoglobin—Methotrexate—bone cancer	0.00286	0.00301	CcSEcCtD
Remifentanil—Haemorrhage—Methotrexate—bone cancer	0.00285	0.00299	CcSEcCtD
Remifentanil—Sweating—Epirubicin—bone cancer	0.00284	0.00299	CcSEcCtD
Remifentanil—Haematuria—Epirubicin—bone cancer	0.00283	0.00297	CcSEcCtD
Remifentanil—Pharyngitis—Methotrexate—bone cancer	0.00282	0.00297	CcSEcCtD
Remifentanil—Hyperglycaemia—Doxorubicin—bone cancer	0.00278	0.00292	CcSEcCtD
Remifentanil—Pneumonia—Doxorubicin—bone cancer	0.00276	0.0029	CcSEcCtD
Remifentanil—Visual impairment—Methotrexate—bone cancer	0.00274	0.00288	CcSEcCtD
Remifentanil—Hypersensitivity—Cisplatin—bone cancer	0.00271	0.00285	CcSEcCtD
Remifentanil—Bradycardia—Epirubicin—bone cancer	0.00271	0.00285	CcSEcCtD
Remifentanil—Renal failure—Doxorubicin—bone cancer	0.0027	0.00284	CcSEcCtD
Remifentanil—Haemoglobin—Epirubicin—bone cancer	0.00268	0.00281	CcSEcCtD
Remifentanil—Haemorrhage—Epirubicin—bone cancer	0.00266	0.0028	CcSEcCtD
Remifentanil—Pharyngitis—Epirubicin—bone cancer	0.00264	0.00278	CcSEcCtD
Remifentanil—Cardiac disorder—Methotrexate—bone cancer	0.00264	0.00278	CcSEcCtD
Remifentanil—Sweating—Doxorubicin—bone cancer	0.00263	0.00277	CcSEcCtD
Remifentanil—Haematuria—Doxorubicin—bone cancer	0.00262	0.00275	CcSEcCtD
Remifentanil—Angiopathy—Methotrexate—bone cancer	0.00258	0.00271	CcSEcCtD
Remifentanil—Immune system disorder—Methotrexate—bone cancer	0.00257	0.0027	CcSEcCtD
Remifentanil—Visual impairment—Epirubicin—bone cancer	0.00257	0.0027	CcSEcCtD
Remifentanil—Mediastinal disorder—Methotrexate—bone cancer	0.00256	0.00269	CcSEcCtD
Remifentanil—Chills—Methotrexate—bone cancer	0.00255	0.00268	CcSEcCtD
Remifentanil—Diarrhoea—Cisplatin—bone cancer	0.00252	0.00265	CcSEcCtD
Remifentanil—Bradycardia—Doxorubicin—bone cancer	0.00251	0.00264	CcSEcCtD
Remifentanil—Erythema—Methotrexate—bone cancer	0.00248	0.0026	CcSEcCtD
Remifentanil—Haemoglobin—Doxorubicin—bone cancer	0.00248	0.0026	CcSEcCtD
Remifentanil—Flushing—Epirubicin—bone cancer	0.00247	0.0026	CcSEcCtD
Remifentanil—Cardiac disorder—Epirubicin—bone cancer	0.00247	0.0026	CcSEcCtD
Remifentanil—Haemorrhage—Doxorubicin—bone cancer	0.00246	0.00259	CcSEcCtD
Remifentanil—Pharyngitis—Doxorubicin—bone cancer	0.00245	0.00257	CcSEcCtD
Remifentanil—Angiopathy—Epirubicin—bone cancer	0.00242	0.00254	CcSEcCtD
Remifentanil—Immune system disorder—Epirubicin—bone cancer	0.00241	0.00253	CcSEcCtD
Remifentanil—Mediastinal disorder—Epirubicin—bone cancer	0.0024	0.00252	CcSEcCtD
Remifentanil—Chills—Epirubicin—bone cancer	0.00239	0.00251	CcSEcCtD
Remifentanil—Arrhythmia—Epirubicin—bone cancer	0.00238	0.0025	CcSEcCtD
Remifentanil—Visual impairment—Doxorubicin—bone cancer	0.00237	0.0025	CcSEcCtD
Remifentanil—Vomiting—Cisplatin—bone cancer	0.00234	0.00246	CcSEcCtD
Remifentanil—Rash—Cisplatin—bone cancer	0.00232	0.00244	CcSEcCtD
Remifentanil—Dermatitis—Cisplatin—bone cancer	0.00232	0.00244	CcSEcCtD
Remifentanil—Erythema—Epirubicin—bone cancer	0.00232	0.00244	CcSEcCtD
Remifentanil—Anaemia—Methotrexate—bone cancer	0.00229	0.00241	CcSEcCtD
Remifentanil—Cardiac disorder—Doxorubicin—bone cancer	0.00229	0.0024	CcSEcCtD
Remifentanil—Flushing—Doxorubicin—bone cancer	0.00229	0.0024	CcSEcCtD
Remifentanil—Angiopathy—Doxorubicin—bone cancer	0.00224	0.00235	CcSEcCtD
Remifentanil—Immune system disorder—Doxorubicin—bone cancer	0.00223	0.00234	CcSEcCtD
Remifentanil—Mediastinal disorder—Doxorubicin—bone cancer	0.00222	0.00233	CcSEcCtD
Remifentanil—Chills—Doxorubicin—bone cancer	0.00221	0.00232	CcSEcCtD
Remifentanil—Arrhythmia—Doxorubicin—bone cancer	0.0022	0.00231	CcSEcCtD
Remifentanil—Nausea—Cisplatin—bone cancer	0.00219	0.0023	CcSEcCtD
Remifentanil—Cough—Methotrexate—bone cancer	0.00216	0.00227	CcSEcCtD
Remifentanil—Convulsion—Methotrexate—bone cancer	0.00215	0.00226	CcSEcCtD
Remifentanil—Erythema—Doxorubicin—bone cancer	0.00214	0.00225	CcSEcCtD
Remifentanil—Anaemia—Epirubicin—bone cancer	0.00214	0.00225	CcSEcCtD
Remifentanil—Agitation—Epirubicin—bone cancer	0.00213	0.00224	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00209	0.0022	CcSEcCtD
Remifentanil—Syncope—Epirubicin—bone cancer	0.00208	0.00218	CcSEcCtD
Remifentanil—Confusional state—Methotrexate—bone cancer	0.00204	0.00214	CcSEcCtD
Remifentanil—Loss of consciousness—Epirubicin—bone cancer	0.00204	0.00214	CcSEcCtD
Remifentanil—Cough—Epirubicin—bone cancer	0.00202	0.00213	CcSEcCtD
Remifentanil—Anaphylactic shock—Methotrexate—bone cancer	0.00202	0.00212	CcSEcCtD
Remifentanil—Convulsion—Epirubicin—bone cancer	0.00201	0.00211	CcSEcCtD
Remifentanil—Hypertension—Epirubicin—bone cancer	0.002	0.0021	CcSEcCtD
Remifentanil—Nervous system disorder—Methotrexate—bone cancer	0.00198	0.00208	CcSEcCtD
Remifentanil—Anaemia—Doxorubicin—bone cancer	0.00198	0.00208	CcSEcCtD
Remifentanil—Thrombocytopenia—Methotrexate—bone cancer	0.00198	0.00208	CcSEcCtD
Remifentanil—Agitation—Doxorubicin—bone cancer	0.00197	0.00207	CcSEcCtD
Remifentanil—Anxiety—Epirubicin—bone cancer	0.00197	0.00207	CcSEcCtD
Remifentanil—Skin disorder—Methotrexate—bone cancer	0.00196	0.00206	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00196	0.00206	CcSEcCtD
Remifentanil—Hyperhidrosis—Methotrexate—bone cancer	0.00195	0.00205	CcSEcCtD
Remifentanil—Dry mouth—Epirubicin—bone cancer	0.00193	0.00203	CcSEcCtD
Remifentanil—Syncope—Doxorubicin—bone cancer	0.00192	0.00202	CcSEcCtD
Remifentanil—Confusional state—Epirubicin—bone cancer	0.00191	0.002	CcSEcCtD
Remifentanil—Oedema—Epirubicin—bone cancer	0.00189	0.00199	CcSEcCtD
Remifentanil—Anaphylactic shock—Epirubicin—bone cancer	0.00189	0.00199	CcSEcCtD
Remifentanil—Hypotension—Methotrexate—bone cancer	0.00189	0.00199	CcSEcCtD
Remifentanil—Loss of consciousness—Doxorubicin—bone cancer	0.00189	0.00198	CcSEcCtD
Remifentanil—Cough—Doxorubicin—bone cancer	0.00187	0.00197	CcSEcCtD
Remifentanil—Shock—Epirubicin—bone cancer	0.00186	0.00196	CcSEcCtD
Remifentanil—Convulsion—Doxorubicin—bone cancer	0.00186	0.00195	CcSEcCtD
Remifentanil—Nervous system disorder—Epirubicin—bone cancer	0.00186	0.00195	CcSEcCtD
Remifentanil—Thrombocytopenia—Epirubicin—bone cancer	0.00185	0.00195	CcSEcCtD
Remifentanil—Hypertension—Doxorubicin—bone cancer	0.00185	0.00195	CcSEcCtD
Remifentanil—Tachycardia—Epirubicin—bone cancer	0.00185	0.00194	CcSEcCtD
Remifentanil—Skin disorder—Epirubicin—bone cancer	0.00184	0.00193	CcSEcCtD
Remifentanil—Hyperhidrosis—Epirubicin—bone cancer	0.00183	0.00192	CcSEcCtD
Remifentanil—Anxiety—Doxorubicin—bone cancer	0.00182	0.00191	CcSEcCtD
Remifentanil—Paraesthesia—Methotrexate—bone cancer	0.00182	0.00191	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00181	0.00191	CcSEcCtD
Remifentanil—Dyspnoea—Methotrexate—bone cancer	0.0018	0.00189	CcSEcCtD
Remifentanil—Somnolence—Methotrexate—bone cancer	0.0018	0.00189	CcSEcCtD
Remifentanil—Dry mouth—Doxorubicin—bone cancer	0.00179	0.00188	CcSEcCtD
Remifentanil—Dyspepsia—Methotrexate—bone cancer	0.00178	0.00187	CcSEcCtD
Remifentanil—Hypotension—Epirubicin—bone cancer	0.00177	0.00186	CcSEcCtD
Remifentanil—Confusional state—Doxorubicin—bone cancer	0.00176	0.00185	CcSEcCtD
Remifentanil—Anaphylactic shock—Doxorubicin—bone cancer	0.00175	0.00184	CcSEcCtD
Remifentanil—Oedema—Doxorubicin—bone cancer	0.00175	0.00184	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Methotrexate—bone cancer	0.00175	0.00183	CcSEcCtD
Remifentanil—Pain—Methotrexate—bone cancer	0.00173	0.00182	CcSEcCtD
Remifentanil—Shock—Doxorubicin—bone cancer	0.00172	0.00181	CcSEcCtD
Remifentanil—Nervous system disorder—Doxorubicin—bone cancer	0.00172	0.0018	CcSEcCtD
Remifentanil—Thrombocytopenia—Doxorubicin—bone cancer	0.00171	0.0018	CcSEcCtD
Remifentanil—Tachycardia—Doxorubicin—bone cancer	0.00171	0.0018	CcSEcCtD
Remifentanil—Skin disorder—Doxorubicin—bone cancer	0.0017	0.00179	CcSEcCtD
Remifentanil—Paraesthesia—Epirubicin—bone cancer	0.0017	0.00179	CcSEcCtD
Remifentanil—Hyperhidrosis—Doxorubicin—bone cancer	0.00169	0.00178	CcSEcCtD
Remifentanil—Dyspnoea—Epirubicin—bone cancer	0.00169	0.00177	CcSEcCtD
Remifentanil—Somnolence—Epirubicin—bone cancer	0.00168	0.00177	CcSEcCtD
Remifentanil—Feeling abnormal—Methotrexate—bone cancer	0.00167	0.00175	CcSEcCtD
Remifentanil—Dyspepsia—Epirubicin—bone cancer	0.00167	0.00175	CcSEcCtD
Remifentanil—Hypotension—Doxorubicin—bone cancer	0.00164	0.00172	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Epirubicin—bone cancer	0.00163	0.00172	CcSEcCtD
Remifentanil—Pain—Epirubicin—bone cancer	0.00162	0.0017	CcSEcCtD
Remifentanil—Constipation—Epirubicin—bone cancer	0.00162	0.0017	CcSEcCtD
Remifentanil—Urticaria—Methotrexate—bone cancer	0.00161	0.00169	CcSEcCtD
Remifentanil—Body temperature increased—Methotrexate—bone cancer	0.0016	0.00168	CcSEcCtD
Remifentanil—Paraesthesia—Doxorubicin—bone cancer	0.00157	0.00165	CcSEcCtD
Remifentanil—Dyspnoea—Doxorubicin—bone cancer	0.00156	0.00164	CcSEcCtD
Remifentanil—Feeling abnormal—Epirubicin—bone cancer	0.00156	0.00164	CcSEcCtD
Remifentanil—Somnolence—Doxorubicin—bone cancer	0.00156	0.00164	CcSEcCtD
Remifentanil—Dyspepsia—Doxorubicin—bone cancer	0.00154	0.00162	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00151	0.00159	CcSEcCtD
Remifentanil—Urticaria—Epirubicin—bone cancer	0.0015	0.00158	CcSEcCtD
Remifentanil—Pain—Doxorubicin—bone cancer	0.0015	0.00157	CcSEcCtD
Remifentanil—Constipation—Doxorubicin—bone cancer	0.0015	0.00157	CcSEcCtD
Remifentanil—Body temperature increased—Epirubicin—bone cancer	0.0015	0.00157	CcSEcCtD
Remifentanil—Hypersensitivity—Methotrexate—bone cancer	0.00149	0.00157	CcSEcCtD
Remifentanil—Feeling abnormal—Doxorubicin—bone cancer	0.00144	0.00152	CcSEcCtD
Remifentanil—Pruritus—Methotrexate—bone cancer	0.00143	0.0015	CcSEcCtD
Remifentanil—Hypersensitivity—Epirubicin—bone cancer	0.00139	0.00146	CcSEcCtD
Remifentanil—Urticaria—Doxorubicin—bone cancer	0.00139	0.00146	CcSEcCtD
Remifentanil—Body temperature increased—Doxorubicin—bone cancer	0.00138	0.00145	CcSEcCtD
Remifentanil—Diarrhoea—Methotrexate—bone cancer	0.00138	0.00145	CcSEcCtD
Remifentanil—Pruritus—Epirubicin—bone cancer	0.00134	0.00141	CcSEcCtD
Remifentanil—Dizziness—Methotrexate—bone cancer	0.00134	0.0014	CcSEcCtD
Remifentanil—Diarrhoea—Epirubicin—bone cancer	0.00129	0.00136	CcSEcCtD
Remifentanil—Hypersensitivity—Doxorubicin—bone cancer	0.00129	0.00136	CcSEcCtD
Remifentanil—Vomiting—Methotrexate—bone cancer	0.00129	0.00135	CcSEcCtD
Remifentanil—Rash—Methotrexate—bone cancer	0.00127	0.00134	CcSEcCtD
Remifentanil—Dermatitis—Methotrexate—bone cancer	0.00127	0.00134	CcSEcCtD
Remifentanil—Headache—Methotrexate—bone cancer	0.00127	0.00133	CcSEcCtD
Remifentanil—Dizziness—Epirubicin—bone cancer	0.00125	0.00131	CcSEcCtD
Remifentanil—Pruritus—Doxorubicin—bone cancer	0.00124	0.0013	CcSEcCtD
Remifentanil—Vomiting—Epirubicin—bone cancer	0.0012	0.00126	CcSEcCtD
Remifentanil—Nausea—Methotrexate—bone cancer	0.0012	0.00126	CcSEcCtD
Remifentanil—Diarrhoea—Doxorubicin—bone cancer	0.0012	0.00126	CcSEcCtD
Remifentanil—Rash—Epirubicin—bone cancer	0.00119	0.00125	CcSEcCtD
Remifentanil—Dermatitis—Epirubicin—bone cancer	0.00119	0.00125	CcSEcCtD
Remifentanil—Headache—Epirubicin—bone cancer	0.00119	0.00125	CcSEcCtD
Remifentanil—Dizziness—Doxorubicin—bone cancer	0.00116	0.00122	CcSEcCtD
Remifentanil—Nausea—Epirubicin—bone cancer	0.00112	0.00118	CcSEcCtD
Remifentanil—Vomiting—Doxorubicin—bone cancer	0.00111	0.00117	CcSEcCtD
Remifentanil—Rash—Doxorubicin—bone cancer	0.0011	0.00116	CcSEcCtD
Remifentanil—Dermatitis—Doxorubicin—bone cancer	0.0011	0.00116	CcSEcCtD
Remifentanil—Headache—Doxorubicin—bone cancer	0.0011	0.00115	CcSEcCtD
Remifentanil—Nausea—Doxorubicin—bone cancer	0.00104	0.00109	CcSEcCtD
